CLOV (Clover Health Investments) EBIT: $-57 Mil (TTM As of Mar. 2026)


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.21
GF Value $3.95
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments EBIT?

Clover Health Investments CLOV +3.17% 81 EBIT is $-57 Mil as of Mar. 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.95 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Clover Health Investments's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $27 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-57 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Clover Health Investments's annualized ROC % for the quarter that ended in Mar. 2026 was 44.45%. Clover Health Investments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1,645.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Clover Health Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -2.36%.

Clover Health Investments  (NAS:CLOV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Clover Health Investments's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=109.336 * ( 1 - 0% )/( (236.48 + 255.473)/ 2 )
=109.336/245.9765
=44.45 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=541.011 - 205.499 - ( 120.256 - max(0, 208.823 - 307.855+120.256))
=236.48

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=697.728 - 330.817 - ( 203.543 - max(0, 336.583 - 448.021+203.543))
=255.473

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Clover Health Investments's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=109.336/( ( (6.385 + max(-179.965, 0)) + (6.904 + max(-294.794, 0)) )/ 2 )
=109.336/( ( 6.385 + 6.904 )/ 2 )
=109.336/6.6445
=1,645.51 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 28.858) - (205.499 + 0 + 3.324)
=-179.965

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 41.789) - (330.817 + 0 + 5.766)
=-294.794

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Clover Health Investments's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-56.941/2414.639
=-2.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments EBIT Related Terms

Clover Health Investments EBIT Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments EBIT Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -570.85 -253.22 -210.14 -46.27 -85.55

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.27 -10.56 -24.38 -49.34 27.33

CLOV vs PGNY, ALHC, PFHO: EBIT Comparison

For the Healthcare Plans subindustry, Clover Health Investments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Health Investments EV-to-EBIT vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's EV-to-EBIT falls into.


CLOV
81GF Score
Clover Health Investments Corp CLOV
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-57 Mil mean?
Clover Health Investments (CLOV) has a EBIT of $-57 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Clover Health Investments.
Is Clover Health Investments' EBIT too high?
Clover Health Investments' current EBIT is $-57 Mil. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' EBIT compare to PGNY and ALHC?
Clover Health Investments' EBIT of $-57 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Plans company?
A good EBIT depends on the Healthcare Plans industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Clover Health Investments. Clover Health Investments's current EBIT is $-57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.95, compared to a current price of $5.21 — trading 31.9% above its estimated fair value. The current EBIT is $-57 Mil. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current EBIT is $-57 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.21 is trading 31.9% above its estimated GF Value™ of $3.95. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

  • EBIT: $-57 Mil
  • GF Value™: $3.95 vs. price of $5.21 (31.9% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$3.95
GF Value